Reduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment
Abstract Epidermolysis bullosa acquisita (EBA) is a difficult-to-treat subepidermal autoimmune blistering skin disease (AIBD) with circulating and tissue-bound anti-type VII collagen antibodies. Different reports have indicated increased concentration of tumor necrosis factor α (TNF) in the serum an...
Main Authors: | Misa Hirose, Anika Kasprick, Foteini Beltsiou, Katharina Schulze Dieckhoff, Franziska Sophie Schulze, Unni K J S R L Samavedam, Jennifer E Hundt, Hendri H Pas, Marcel F Jonkman, Enno Schmidt, Kathrin Kalies, Detlef Zillikens, Ralf J Ludwig, Katja Bieber |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-12-01
|
Series: | Molecular Medicine |
Online Access: | http://link.springer.com/article/10.2119/molmed.2015.00206 |
Similar Items
-
Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita
by: Unni K. Samavedam, et al.
Published: (2018-02-01) -
Epidermolysis Bullosa Acquisita: The 2019 Update
by: Hiroshi Koga, et al.
Published: (2019-01-01) -
Epidermolysis bullosa acquisita
by: V. V. Chikin, et al.
Published: (2017-08-01) -
Direct Immunofluorescence of Mechanobullous Epidermolysis Bullosa Acquisita, Porphyria Cutanea Tarda and Pseudoporphyria
by: Heleen J. de Groot, et al.
Published: (2018-09-01) -
Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita
by: Hiroshi Koga, et al.
Published: (2018-07-01)